Louisiana Cannabis Software

How Louisiana Regulates Cannabis Licenses

Louisiana operates one of the most structurally distinctive cannabis programs in the country. The state's program governs cannabis exclusively as a medical matter, referred to throughout state law as therapeutic marijuana. The governing statute is La. R.S. 40:1046, and operational requirements are codified in Louisiana Administrative Code Title 51, Part XXIX (the Public Health–Sanitary Code). The Louisiana Department of Health (LDH), Office of Public Health, Bureau of Sanitarian Services is the primary regulatory authority, responsible for issuing manufacturer licenses, retail permits, and laboratory licenses, conducting inspections, and enforcing compliance statewide. The program's sunset date has been extended to July 1, 2030 under Act 150 of the 2024 Regular Legislature.

Louisiana's licensing framework is organized around three categories of cannabis business: Manufacturer (Licensee), Retailer, and Testing Laboratory. The number of manufacturer licenses is capped at two by statute, and the number of retail permits is capped at thirty total locations ten primary sites and up to twenty approved satellite locations. Adult-use cannabis remains illegal in Louisiana. All medical marijuana must be produced in-state; no product from out-of-state sources may be sold at Louisiana retail locations. All licensed businesses are required to use the Louisiana Medical Marijuana Tracking System (LMMTS) for seed-to-sale tracking of all cannabis activity.

Manufacturer License

The Manufacturer License referred to in Louisiana law and regulations as a Licensee authorizes an entity to cultivate, extract, process, produce, and transport therapeutic marijuana within Louisiana. No more than two Manufacturer Licenses may exist in the state at any time, a cap set directly in La. R.S. 40:1046. As of 2026, the two licensed manufacturers are Advanced Biomedics LLC (dba Ilera Holistic Healthcare) and Good Day Farm Louisiana LLC. These licenses were formally transferred to the private entities on July 1, 2024, pursuant to Act 150 of the 2024 Regular Legislature, which removed the prior requirement that licenses be held by the LSU Agricultural Center and Southern University Agricultural Center. The current licensees are those entities that held contracts with those universities as of January 1, 2024.

Each Manufacturer License is subject to an annual administration fee of $100,000. Licenses are nontransferable and renew annually on July 1. A license in force shall be renewed by the department upon proper application and payment of required fees. New licenses may only be issued under two specific circumstances: a current licensee voluntarily surrenders its active license, or a current licensee fails to renew within the required timeframe specifically, if the licensee fails to respond to written notice from the department with the necessary documentation and fees within a thirty-day window. When a new license does become available, it is awarded through a competitive bid process in accordance with the Louisiana Procurement Code (R.S. 39:1551 et seq.). There is no open application window for manufacturer licensure outside of these circumstances.

Every manufacturer must possess and maintain the hardware and software required to connect to the Louisiana Medical Marijuana Tracking System (LMMTS). Licensed facilities must maintain inventory records, including marijuana waste, and update those records no less frequently than once per week. Before transporting any medical marijuana to a retailer, laboratory, contractor, or disposal site, manufacturers must generate a complete inventory manifest. Manufacturers must also maintain material safety data sheets (MSDS) for all chemicals in use at the facility.

Every batch of product must be sampled and tested before release. No batch may be released for sale until a representative sample has been verified as compliant and a certificate of analysis has been issued by an approved laboratory to both the department and the originating manufacturer, within 24 hours of testing completion. Batches failing one or more tests may be remediated once; if a subsequent sample still fails, the batch must be destroyed. Product must meet Louisiana's quality standards, including a mold and yeast limit of fewer than 100,000 colony-forming units per gram (CFU/g) and pesticide residue levels that comply with the Maximum Contaminant Levels set out in the January 2026 Final Rule limits that mirror Oregon's pesticide testing schedule as adopted by LDH through the 2025 Emergency Rule.

Routine inspections of licensed manufacturing facilities occur no less than twice per fiscal year. Complaint-based inspections may be conducted at any time during business hours and without prior notice. As a condition of licensure, manufacturers must allow the State Health Officer or their designee to review all records relevant to facility operations and management. Applications for initial licensure must include, among other materials, a complete recall plan and a description of all plans, procedures, and protocols required under R.S. 40:1046.

Retailer Permit

The Retailer Permit authorizes a facility to sell therapeutic marijuana products to patients and caregivers. Retailers were previously referred to as dispensaries and regulated by the Louisiana Board of Pharmacy; Act 693 of the 2024 Regular Legislature transferred all retailer oversight to the Louisiana Department of Health effective January 1, 2025. The January 2026 Final Rule enacted a new Subpart 2 to LAC 51:XXIX establishing the full operational framework for retailers under LDH authority.

The total number of retail permits is statutorily limited to 30 locations statewide a maximum of 10 primary retail sites (one per region, aligned to Louisiana's nine retail regions) and up to 2 satellite locations per primary retailer, for a maximum of 20 satellites. As of 2026, all 10 primary permit slots are filled and no new primary retail permits are being accepted. A permit application may only be submitted when an existing permit-holder surrenders a primary or satellite permit or when a facility undergoes a change of ownership.

Retail permits are not transferable to other locations or owners. Renewal packets must be submitted to LDH no later than December 1 to renew for the following calendar year. Permits not renewed by December 31 are subject to suspension. Permits not renewed by March 1 of the subsequent year, or permits held by operators documented as being in violation of program requirements, may be subject to revocation.

Each permitted retailer must designate at least one registered pharmacist to be available to the primary site and all satellite locations during hours of operation by physical presence or by telephone or videoconference. Retailers must also supply LDH with quarterly registered patient counts based on the previous 24-month period as a condition of permitting.

Retailers may only stock marijuana products obtained from in-state licensed manufacturers. No out-of-state product may be used to supply Louisiana patients under any circumstance. Allowable dosage forms include oils, extracts, tinctures, and sprays; solid oral dosage forms such as pills, capsules, and tablets; liquid oral dosage forms including solutions and suspensions; gelatin- or pectin-based chewables; topical creams, unguents, and lotions; transdermal patches; suppositories; metered-dose inhalers; edible products intended for ingestion; and combustible forms intended for inhalation made from marijuana flower. No therapeutic marijuana product may be incorporated into an alcoholic beverage, a dietary supplement, or any drug other than marijuana, cannabis extracts, or cannabis derivatives.

Retailers must maintain a point-of-sale system that interfaces with the LMMTS to support seed-to-sale tracking of all transactions, including deliveries and waste disposal. Before every sale, retailers must cross-reference the patient's sales history in the LMMTS to ensure no patient receives more than 71 grams of raw marijuana flower in any 14-day period, or any amount of another dosage form in excess of the authorized clinician's recommendation. A retailer must refuse a sale if this cross-reference indicates the limit has been reached.

Patient recommendations must be received directly from an authorized clinician and must include the clinician's name, address, and phone number; the patient's name, address, and date of birth; the qualifying debilitating condition; any contraindicated dosage forms; the date of recommendation; and an expiration date not to exceed 12 months from the date of issuance. A retailer may use one recommendation for multiple fulfillments as long as those fulfillments remain within the authorized limits.

Retailers may provide home delivery to patients and caregivers, but no delivery may be made to an address outside the state of Louisiana. Deliveries must be made available at least once per month per ZIP code serviced. Any product from an incomplete delivery must be returned to the originating retailer; if packaging integrity cannot be verified, the product must be disposed of and the disposal documented in the POS system.

Marijuana product waste that is no longer suitable for sale must be stored in a temporary morgue area on the premises and may not remain there longer than 30 days. Before transport, waste must be rendered into a non-usable state by grinding and mixing with non-marijuana waste materials yard waste, paper or cardboard, plastic, or soil such that the end product is at least 50% non-marijuana waste by volume. This mixed waste may then be disposed of by composting, incineration, or compaction and subsurface burial. Every disposal activity must be documented in the facility's POS system.

Permitted retailers are required to be inspected at least once annually. Complaint-based inspections may be conducted during business hours without prior notice. Permits must be displayed in a prominent location on the premises. Inventory reconciliations must be conducted at least semi-annually (every six months), and reconciliation records must be maintained on the premises for at least two calendar years.

Testing Laboratory License

Prior to analyzing, testing, or handling therapeutic marijuana in Louisiana, an entity must obtain a therapeutic marijuana laboratory license from the Louisiana Department of Health by submitting an initial license application. Laboratories must provide proof of accreditation by the National Institute on Drug Abuse, the National Environmental Laboratory Accreditation Conference (NELAC), the International Organization for Standardization (ISO), or another accrediting entity approved by the department. All licensed laboratories are required to use the Louisiana Medical Marijuana Tracking System (LMMTS) and must meet all requirements set forth in La. R.S. 40:1046 and the applicable provisions of LAC 51:XXIX.

Manufacturers are required to use only LDH-approved laboratories for the testing of medical marijuana. Certificates of analysis from laboratories must be issued to both the manufacturer and the department no later than 24 hours after testing is complete. Laboratories are subject to reasonable inspection by the department as a condition of their license.

Key Compliance Considerations for Louisiana Operators

Louisiana's two-license cap on manufacturing is the most consequential structural constraint in the program. Because no open licensing window exists and new licenses are only triggered by voluntary surrender or forfeiture, there is effectively no pathway for new entrants into the manufacturing segment outside of a competitive bid process following one of those two triggering events. Operators in other states who monitor Louisiana's market should be aware that the program's architecture is deliberately insular the legislature designed it this way, and Act 150 of 2024 extended that framework to 2030 without expansion.

The nontransferability of both manufacturer licenses and retail permits is a compliance and transactional risk that operators must plan around carefully. A licensed manufacturer or retailer cannot simply sell its license or permit to a new owner. Any change of ownership at a retail location requires the surrender of the existing permit and submission of a new application packet including detailed facility plans, staffing information, a designated pharmacist, and a sworn affidavit confirming separation distance compliance. Operators acquiring cannabis businesses in Louisiana through asset or stock transactions should confirm the regulatory pathway for permit continuity with the department before closing.

The 71-gram flower limit per patient per 14-day period is enforced in real time through the LMMTS cross-reference requirement. Retailers are legally obligated to refuse a sale when the cross-reference shows a patient is at or near their limit regardless of whether the patient presents a valid recommendation. A retailer that fails to perform the cross-reference before sale, or that completes a sale that pushes a patient over the limit, is in direct violation of LAC 51:XXIX §2505.

The prohibition on out-of-state product sourcing operates as an absolute rule. A retailer that stocks or dispenses any marijuana product not manufactured by one of Louisiana's two licensed manufacturers even temporarily, even in a shortage situation is operating outside the scope of its permit. Louisiana law has no emergency sourcing provision or out-of-state supply contingency. This supply dependency on two manufacturers creates meaningful operational risk for retailers in the event of a production disruption at either facility.

Waste disposal timing is one of the more operationally specific requirements in Louisiana's retail rules. The 30-day maximum hold on unsaleable product is strictly enforced, and failure to document disposal activities in the POS system constitutes a separate compliance violation from the failure to dispose of the product itself. Retailers should establish regular disposal schedules rather than relying on ad hoc removal, particularly for satellite locations where oversight may be less frequent.